They have demonstrated effectiveness in supporting significant weight loss and improving metabolic health
It produces results, but in a head-to-head comparison with semaglutide, it only caused a 6.4% reduction in body weight
Ana Sandoiu, MA Author Ana Sandoiu is a freelance medical copywriter, editor, and health journalist with a decade of experience in content creation
As patents for several GLP-1 drugs approach expiration, many pharmaceutical companies are developing biosimilar or follow-on versions
In patients with diabetes, review of glucose monitoring data can identify problematic glycemic patterns
When asked whether he foresaw the full extent of the opioid crisis from his earlier work, he said one development that surprised him was that other drug companies would be so foolish as to adopt essentially the same marketing tactics that Purdue had adopted. The way Hanly explains it, some judges will be in the pocket of big pharma. Corporate America is looking for any way to make the playing field unlevel. The pharmaceutical industry and its allies have their own view of lawyers like Hanly